Literature DB >> 31534904

Severe Spinal Surgery Infection and Local Ozone Therapy as Complementary Treatment: A Case Report.

Josip Buric1, Pedro Berjano2, Marco Damilano2.   

Abstract

BACKGROUND: Infection is a serious surgical complication that significantly increases morbidity and mortality rates as well as health care expenses. Increased bacterial resistance to antibiotics makes the treatment of such events even more troublesome.
OBJECTIVE: To report on a surgical infection case treated with ozone as a complementary therapy. METHODS AND MATERIALS: A female, 65 years old, submitted to a complex surgical procedure for adult kyphotic deformity correction that presented with early postsurgical infection. The patient was treated with revision surgery and antibiotics that improved the condition but were unable to delete the infection. Ozone, in its gaseous form, was injected subcutaneously and paravertebrally twice weekly for 3 weeks.
RESULTS: After 3 weeks of treatment, the wound healed completely. Follow-up visits and laboratory exams for up to 1 year after surgery showed no recurrence of infection.
CONCLUSIONS: Although just a single case, topical ozone therapy for surgical infections showed promising potential in this specific case.

Entities:  

Keywords:  antibiotic resistance; ozone therapy; surgical infections

Year:  2019        PMID: 31534904      PMCID: PMC6727790          DOI: 10.14444/6050

Source DB:  PubMed          Journal:  Int J Spine Surg        ISSN: 2211-4599


  27 in total

Review 1.  Wound microbiology and associated approaches to wound management.

Authors:  P G Bowler; B I Duerden; D G Armstrong
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Postoperative deep wound infection in adults after posterior lumbosacral spine fusion with instrumentation: incidence and management.

Authors:  R Picada; R B Winter; J E Lonstein; F Denis; M R Pinto; M D Smith; J H Perra
Journal:  J Spinal Disord       Date:  2000-02

3.  Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index.

Authors:  R P Gaynes; D H Culver; T C Horan; J R Edwards; C Richards; J S Tolson
Journal:  Clin Infect Dis       Date:  2001-09-01       Impact factor: 9.079

Review 4.  The crisis in antibiotic resistance.

Authors:  H C Neu
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

5.  Superficially, longer, intermittent ozone theraphy in the treatment of the chronic, infected wounds.

Authors:  Dariusz Białoszewski; Michał Kowalewski
Journal:  Ortop Traumatol Rehabil       Date:  2003-10-30

6.  Efficiency of tazobactam/piperacillin in lethal peritonitis is enhanced after preconditioning of rats with O3/O2-pneumoperitoneum.

Authors:  Michael Bette; Rolf M Nüsing; Reinier Mutters; Zullyt B Zamora; Silvia Menendez; Siegfried Schulz
Journal:  Shock       Date:  2006-01       Impact factor: 3.454

7.  Risk factors for infection after spinal surgery.

Authors:  Andrew Fang; Serena S Hu; Nathan Endres; David S Bradford
Journal:  Spine (Phila Pa 1976)       Date:  2005-06-15       Impact factor: 3.468

8.  An in vitro evaluation of the ability of ozone to kill a strain of Enterococcus faecalis.

Authors:  R S Hems; K Gulabivala; Y-L Ng; D Ready; D A Spratt
Journal:  Int Endod J       Date:  2005-01       Impact factor: 5.264

9.  Investigating antibody-catalyzed ozone generation by human neutrophils.

Authors:  Bernard M Babior; Cindy Takeuchi; Julie Ruedi; Abel Gutierrez; Paul Wentworth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-24       Impact factor: 11.205

10.  Risk factors for surgical site infection in spinal surgery.

Authors:  Margaret A Olsen; Jennie Mayfield; Carl Lauryssen; Louis B Polish; Marilyn Jones; Joshua Vest; Victoria J Fraser
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

View more
  1 in total

1.  Medical ozone induces proliferation and migration inhibition through ROS accumulation and PI3K/AKT/NF-κB suppression in human liver cancer cells in vitro.

Authors:  J Li; T Zeng; S Tang; M Zhong; Q Huang; X Li; X He
Journal:  Clin Transl Oncol       Date:  2021-04-05       Impact factor: 3.405

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.